BACKGROUND The current study was conducted to investigate the dependence between
progression‐free survival (PFS) and overall survival (OS) in patients with metastatic renal …

Introduction Because the treatment landscape for metastatic renal cell carcinoma (mRCC)
has evolved dramatically over the past decade, data on patients' treatment and outcomes in …

Objectives To clarify treatment patterns and outcomes for patients with unresectable or
metastatic renal cell carcinoma in the molecular target therapy era in Japan. Methods A …

BACKGROUND: The increased finding of kidney 'incidentalomas' and more frequent surgery
in patients with renal cell cancer (RCC) metastases may have improved survival from the …

CONTEXT: The expanding armamentarium of agents for the therapy of advanced clear cell
renal cell carcinoma (RCC) warrants further investigation of optimal patient selection …

Objective To evaluate population-based survival trends, compared to optimistic trial
benchmarks, in metastatic renal cell carcinoma (mRCC). Advances in medical therapy for …

Abstract Context The European Association of Urology (EAU) Renal Cell Carcinoma (RCC)
Guideline Panel has prepared evidence-based guidelines and recommendations for the …

The treatment of advanced renal cell carcinoma has been completely changed by the
development of new therapeutic modalities during the past 3 years. In this time period six …

Background: Limited data exist on outcomes for metastatic renal cell carcinoma (mRCC)
patients treated with multiple lines of therapy. Benchmarks for survival are required for …

Although renal cell carcinoma accounts for only 3% of adult malignancies, it has been
increasing in incidence by 2–4% per year since the 1970's. Cigarette smoking, obesity and …